| Licensing & Partnership Opportunity at Bionature Release date: Feb. 11th 2008 |
| Bionature EA, Ltd. is currently seeking world wide Strategic Partners to continue development of its EPO technology for the safer treatment of patients currently receiving EPO. The opportunity also exists for the licensing of specific membrane steroid receptor agonists that is being developed as an anti-tumor agent. Bionature has patent applications filed in the USA and in the EU.
» CLICK HERE TO DOWNLOAD THE FULL PDF For further information, please contact: Constantinos Neophytou |
|
|